Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tobii Dynavox empowers people with ALS to create their own synthetic voice within minutes

Tobii Dynavox , the world leader in assistive technology for communication, announces that it releases a new voice banking integration within its speech-generating software TD Talk , available immediately. Using Acapela Group’s solution My Own Voice , people with conditions such as ALS can easily capture their own unique voice, to create a personalized synthetic voice and use it directly in TD Talk.  For individuals diagnosed with ALS or other conditions resulting in speech

Final result of Sapphire BidCo Ltd’s voluntary public cash tender offer for all the shares in Basware Corporation: Sapphire BidCo Ltd completes the tender offer

Basware Corporation, stock exchange release, 27 June 2022 at 10:00 a.m. EESTNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On 26 April 2022, Sapphire BidCo Ltd (the “Offeror”) commenced a voluntary recommended public cash tender offer to acquire all of the issued and outstanding shares in Basware Corporation (“Basware” or the “Company”) that are not held by Basware or any of

CEO Comment June 2022 – Several Accomplishments & Positive Progress

It’s been a busy and eventful first half of 2022, so I just want to share some thoughts with you as we head into full summer. The fact is that a lot of positive things are happening in the company:  · Actiste[®] is being used in Qatar with the aim to improve the lives of people living with diabetes. · Actiste[®] is being used for clinical research by diabetes patients in the United Kingdom.  · We are getting closer to commercialization in the United Arab Emirates where a number of healthcare facilities have signed up for participation in the upcoming user pilot initiated

Invitation to Immunovia’s Presentation of PanFAM-1 Results

LUND (SWEDEN) – Immunovia will present PanFAM-1 results today, June 27, 2022 at 13:00 pm CET. Analysts, investors and media are invited to a webcast and teleconference. The presentation slides will be available at www.immunovia.com. See also press release published: https://investor.immunovia.com/panfam-1-results-partly-inconclusive/   Philipp Matieu, CEO and President, Thomas King, Medical Director, and Jeff Borcherding, CEO US operations, will present. The presentation will be held in English and be followed by a Q&A session. You are welcome to join via webcast or phone, see details

Sandvik to acquire PCD tools manufacturer Frezite

Sandvik has signed an agreement to acquire 100% of the equity interests of the Portugal-based company Frezigest, SGPS (“Frezite”). Frezite’s offering primarily consists of made-to-order polycrystalline diamond (PCD) tools for metal and wood applications, with exposure to the automotive, general engineering and aerospace segments. The company will be reported within Walter, a division within Sandvik Manufacturing and Machining Solutions. “With the acquisition of Frezite, we take another important step in our shift to growth strategy. We have a clear ambition for our machining solutions

East of England trusts to digitize pathology following a cloud service contract with Sectra

Linköping, Sweden – June 27, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract for digital pathology with East Suffolk and North Essex NHS Foundation Trust and West Suffolk NHS Foundation Trust in the UK. The solution will enable pathologists to review and collaborate around cases in a way that is not possible with microscopes. This will reduce variation and increase efficiency in primary diagnostics, thereby improving cancer care.The two NHS trusts in the East of England will transform pathology services for a

Atlas Copco to acquire a Chinese manufacturer of industrial vacuum pumps and systems

Nacka, Sweden, June 27, 2022: Atlas Copco has agreed to acquire the assets of Shandong Jinggong Pump Co., Ltd. The company develops and manufactures liquid ring vacuum pumps and systems, mainly used in the chemical and other general industries.Shangdong Jinggong Pump, which operates under the brand name Chinco, was founded in 1998 and has 100 employees. The headquarter is located in Zibo, in China’s Shandong province. In 2021, the company had revenues of approximately MUSD 12 (MSEK 102).  "Shangdong Jinggong Pump is an agile company with a strong manufacturing setup and high-quality

Musti Group plc – Managers' transactions – Rönnberg

Musti Group plc – Managers' transactions – Rönnberg Musti Group plc            Managers’ transactions                  27 June 2022, at 9.30am Musti Group Oyj - Managers’ transactions                  _________________________________________ Person subject to the notification requirement Name: David Rönnberg Position: Chief Executive Officer Issuer: Musti Group LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 16381/5/4 ____________________________________________ Transaction date: 2022-06-23 Venue: NASDAQ HELSINKI

Digia and Productivity Leap join forces to create the preconditions for powerful growth, especially in the social welfare and healthcare sector

Digia has a strong foothold in the social welfare and healthcare industry, and the acquisition of Productivity Leap further strengthens Digia’s capabilities as a comprehensive digitalisation partner. The acquisition enables new growth, particularly in social welfare and healthcare, where Digia sees potential for expansion in the coming years.Press release 27 June 2022 at 9:30 a.m. EET On 27 June 2022, Digia Plc and Productivity Leap Oy signed an agreement whereby Digia purchases Productivity Leap’s entire share capital. The acquisition is planned to be completed on 1 July 2022. With the

PanFAM-1 Results Partly Inconclusive

LUND, SWEDEN – Immunovia today announced results from the PanFAM-1 study. The PanFAM-1 study is a prospective, multi-center, investigational study, designed to assess the performance of the IMMray™ PanCan-d test in early detection of pancreatic ductal adenocarcinoma (PDAC) in high-risk populations. The IMMray™ PanCan-d test met its primary endpoint of test specificity comparable to imaging in the study. Sensitivity, however, could not be evaluated due to the low number of PDACs among study participants.   “We aimed for more tangible results of the PanFAM-1 study, which are partly

Vestas to strengthen digital transformation and Development business with new organisational setup and member of Executive Management

News release from Vestas Wind Systems A/SAarhus, 27 June 2022 As the global leader in wind energy, Vestas plays a leading role in providing the solutions and services needed to accelerate the energy transition. To sustain our leading position and help governments and customers address the climate crisis and improve energy security, Vestas will strengthen our organisational focus on our Development Business and our digital transformation. To accelerate our digital transformation, we will establish a new function, Digital Solutions, with the key objective to digitally transform our

Enhertu recommended for breast cancer EU approval

27 June 2022 07:05 BST Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen Recommendation based on DESTINY-Breast03 trial results showing AstraZeneca and Daiichi Sankyo's Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-

Paolo Guglielmini to be appointed new President and CEO for Hexagon

Hexagon AB, a global leader in digital reality solutions, combining sensors, software and autonomous technologies, today announced that Paolo Guglielmini will succeed Ola Rollén as President and CEO of Hexagon AB, effective 31 December 2022. Gun Nilsson has decided to step down as CEO for Hexagon’s principal shareholder MSAB on 1 October and consequently leave her position as Chairman of Hexagon AB at the Annual General Meeting (AGM) 2023. MSAB, in consultation with Hexagon’s nomination committee, has the intention to propose Ola Rollén as new Chairman of the Board at the AGM 2023.

ProtOnART – a new consortium for proton online adaptive radiation therapy

A new consortium for the advancement of Proton Online Adaptive Radiation Therapy, ProtOnART, uniquely brings together researchers, clinicians, and industry. The members of the ProtOnART consortium are OncoRay in Dresden, Germany, and PARTICLE in Leuven, Belgium, both combining academic expertise with clinical experience in proton therapy, as well as industrial partners Ion Beam Applications (IBA), proton therapy system manufacturer from Belgium, and RaySearch Laboratories, provider of oncology software solutions from Sweden.ProtOnART builds upon the partners’ long-standing research efforts

Metso Outotec launches Planet Positive Filtration Plant Units for sustainable performance

Metso Outotec Corporation’s press release on June 27, 2022, at 09:00 a.m. EESTMetso Outotec is launching a comprehensive Filtration Plant Units offering to maximize operational reliability in different types of dewatering applications where superior process performance combined with energy and water efficiency is required. The offering consists of three major plant units around Metso Outotec’s Larox® PF and Larox® FFP, and Metso Outotec CC filter technologies, all designed for the dewatering of concentrates and tailings. The latest addition to the offering is the Larox® FFP3716 Filter

Peab completely renovates Rimnervallen Stadium in Uddevalla

Peab has been commissioned to renovate Rimnersvallen Stadium to meet standards for parasport, Swedish Championships in track and field and Superettan in soccer. The stadium will also be completely accessibility adapted for athletes and the public. The customer is Uddevalla Municipality and the contract is worth SEK 211 million.During the spring Peab has worked on planning the project and preparatory groundwork. The project is now going into production which entails building new stands for around four thousand spectators and four lighting towers and taking measures to handle settlement

Anders Jensen meets European Commissioner Thierry Breton

Anders Jensen, Viaplay Group President and CEO, and Thierry Breton, Commissioner for the Internal Market of the European Union, have met in Brussels to discuss the future competitiveness of Europe’s audiovisual and streaming sector, and the urgent need for supportive policy frameworks that create a more level playing field for ambitious European businesses such as Viaplay Group. Topics at the top of the meeting agenda for Viaplay Group included the Media and Audiovisual Action Plan, the European Media Freedom Act, and removing barriers to market entry and growth. Anders Jensen,

Announcement from Embracer Group’s extra general meeting

The extra general meeting of Embracer Group AB (“Embracer Group”) was held today on 27 June 2022, through postal voting only, and the following resolutions were passed by the meeting.Authorization for the board to issue shares, convertibles and/or warrantsThe extra general meeting resolved, in accordance with the board of directors’proposal, to authorize the board of directors during the period up until the next annual general meeting to, on one or more occasions, resolve to issue B shares, convertibles and/or warrants with right to convert into and subscribe for B shares respectively,

Multiconsult set to deliver services for planned bridge with associated infrastructure in Sarpsborg

Multiconsult (Oslo: MULTI) has been selected as advisor to carry out detailed zoning plan and preliminary technical design for development of bridge crossing at Sarpsfossen for Viken County Municipality (NOR: Viken fylkeskommune). This is a complex project that includes the bridge (NOR name: ny Sarpsbru) with associated infrastructure - with road, footpath and cycle path crossing on each side of the bridge. The assignment will seek various bridge and road solutions and facilitate public transport and shorter and more efficient footpath and cycling path solutions for crossing the river Glomma.

Lynparza recommended in EU for early breast cancer

27 June 2022 07:00 BST Lynparza recommended for approval in the EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer First PARP inhibitor to improve overall survival in early-stage breast cancer AstraZeneca and MSD's Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline BRCA1/2 mutations (gBRCAm) who have HER2-negative high-risk early breast cancer previously

BORR DRILLING LIMITED ENTERS INTO LETTER OF INTENT FOR THE SALE OF THREE JACK-UPS

Hamilton, Bermuda, June 27, 2022: Borr Drilling Limited (the “Company”) (NYSE and OSE: “BORR”) has signed a binding letter of intent with an undisclosed third party for the sale of 3 high-specification units under construction with Keppel FELS shipyard – namely "Tivar", "Huldra" and "Heidrun" (the “Transaction Rigs”). The sale transaction is subject to customary closing conditions and procedures and is expected conclude within 30 days. The Transaction Rigs are expected to be employed by the prospective owner in a captive market and represent limited competition to Borr Drilling’s fleet.

S. Property Group announces agreements with smart urban infrastructure partners; Three Sweden, Vattenfall, and Samsung with its ABB partnership in collaboration to build smart community in Sweden

The Stockholm-based real estate development company, S. Property Group, today announced that it has reached agreements with three smart infrastructure providers: Vattenfall and Three Sweden, and announced a definitive agreement with Samsung Electronics. The parties are jointly arranged to realize the promise of tomorrow’s smart and sustainable urban environments, and through an existing partnership between Samsung Electronics and ABB will deliver the very latest in smart home technologies. In 2022, S. Property Group will begin implementation of its first smart urban infrastructure project at

Chemical recycling of plastic: Neste acquires European rights to Alterra Energy’s thermochemical liquefaction technology

Neste Corporation, Press Release, 27 June 2022 at 8 a.m. (EET)  Alterra Energy’s industrial-scale waste plastics liquefaction unit in Akron, Ohio. Photo: Alterra EnergyNeste has purchased the European rights to Alterra Energy’s liquefaction technology, further solidifying the company’s efforts to advance chemical recycling. Alterra Energy is a US-based company that has developed a proprietary thermochemical solution for liquefaction of hard-to-recycle plastic. In Akron, Ohio, the company is already running an industrial-scale facility that transforms end-of-life plastics into an

Lundbeck and Otsuka Pharmaceutical announce positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole

· Results from a phase III clinical study for treatment of agitation in patients with Alzheimer’s dementia showed that patients treated with brexpiprazole had a statistically significantly greater reduction in agitation compared to placebo · Agitation is a very prevalent clinical manifestation in Alzheimer’s dementia and one of the most complex and stressful aspects of care in patients affected by the disease. It is associated with greater caregiver burden, earlier nursing home placement, increased morbidity and mortality and a substantial economic burden. · Currently there are no FDA

There are no items matching the current filter
There are no more items matching the current filter
Back to top